1. China Stocks

  2. •

    Process industries

  3. •

    Chemicals: specialty
Yibin Tianyuan Group Co., Ltd. Class A

Yibin Tianyuan Group Co., Ltd. Class A

SSZSE:002386
5.35
CNY
+0.06
(+1.13%)
8.07BMarket Cap
2013 Y
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
2025 Y
TTM
Revenue per Share
10.48
14.72
12.28
14.32
17.5
19.44
22.77
21.32
18.54
20.04
14.94
10.27
8.68
- -
Basic EPS, GAAP
0.06
0.1
0.02
0.06
0.12
0.17
0.08
0.11
0.63
0.54
0.03
-0.35
0.07
- -
Free Cash Flow per Basic Share
-0.1
-0.57
-0.05
0.2
-0.28
-0.14
0.24
0.48
0.8
0.66
-1.14
-0.79
-0.99
- -
Dividend per Share
0.5
0.64
0.55
0.41
0.43
0.42
0.31
0.28
0.23
0.39
0.2
0.24
0.15
0.11
Book Value per Share
4.53
4.58
4.59
4.66
4.75
4.9
4.89
4.97
5.57
5.99
6.17
5.74
5.82
5.98
Tangible Book Value per Share
3.6
3.76
3.78
3.81
3.87
4.15
4.34
4.42
5
5.39
5.69
5.26
5.32
5.45
Basic Weighted Avg Shares
873
624
872
873
873
932
1,015
1,015
1,015
1,015
1,230
1,302
1,302
1,302
Sales/Revenue/Turnover
9,152
9,184
10,704
12,502
15,286
18,123
23,103
21,646
18,825
20,339
18,367
13,367
11,299
- -
Operating Margin (%)
2.78
-0.38
0.23
2.35
2.5
3.2
1.87
2.3
5.84
4.12
0.01
-2.03
2.39
- -
Depreciation Expense
499
500
509
486
513
550
573
512
434
487
480
511
555
- -
Net Income, GAAP
56
61
16
55
103
155
79
116
645
551
40
-460
88
- -
Effective Tax Rate (%)
43.11
72.64
115.9
73.49
54.86
19.79
73.96
45.9
14.81
20.59
42.76
- -
74.44
- -
Profit Margin (%)
0.62
0.66
0.15
0.44
0.67
0.86
0.34
0.54
3.42
2.71
0.22
-3.44
0.78
- -
Working Capital
-3,942
-3,868
-3,122
-2,983
-3,179
-2,462
-3,484
-2,745
-2,291
-2,058
-617
-2,382
-2,623
-2,474
LT Debt
1,289
896
1,672
971
233
706
394
919
1,037
1,900
3,340
3,091
3,218
3,440
Total Equity
4,367
4,382
4,370
4,401
4,324
5,121
5,070
5,249
5,856
6,255
8,190
7,626
7,659
7,863
Return on Invested Capital (%)
0.29
-0.64
0.04
0.11
0.99
1.42
0.27
1.01
5.61
4.37
0.24
- -
0.21
- -
Return on Capital (%)
1.65
1.26
0.08
1.23
2.61
4.18
1.78
2.19
6.83
6.22
1.22
- -
1.27
- -
Return on Common Equity (%)
1.43
1.52
0.41
1.37
2.5
3.4
1.58
2.31
12.05
9.39
0.57
-5.93
1.17
- -

Capital Structure

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
ST Debt
4,538
4,611
4,710
LT Borrowings
3,218
3,696
3,440
LT Finance Leases
- -
- -
- -
Preferred Equity and Hybrid Capital
- -
- -
- -
Shares Outstanding
1,302
1,302
1,302
Market Capitalization
7,068
7,784
8,070

Working Capital

CNY

•

in mil. unless spec.
Dec'25
Mar'26
Jun'26
Total Current Assets
6,023
7,636
8,159
Cash, Cash Equivalents & STI
2,501
2,539
2,795
Accounts Receivable, Net
1,057
2,165
2,421
Inventories
1,419
1,652
1,336
Total Current Liabilities
8,645
9,725
10,632
Payables & Accruals
- -
- -
- -
ST Debt
4,538
4,611
4,710
Deferred Revenue
- -
- -
- -

Growth Rates

CNY

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
6.28%
8.57%
0.44%
Free Cash Flow
-122.16%
-52.94%
24.49%
Net Income, GAAP
-64.79%
-204.03%
-119.1%
Sales/Revenue/Turnover
2.14%
-11.47%
-15.47%
Total Cash Common Dividend
-3.89%
1.54%
-36.56%

Quarterly Revenue

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
3,008
3,592
3,375
3,392
13,367
2025
3,141
2,528
- -
2,809
11,299
2026
3,655
3,809
- -
- -
- -

Quarterly Earnings Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
0.01
- -
-0.08
-0.28
-0.35
2025
0.01
- -
- -
0.04
0.07
2026
0.06
0.1
- -
- -
- -

Quarterly Dividends Per Share

CNY

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2024
- -
- -
0.04
0.03
0.24
2025
0.04
0.04
- -
0.03
0.15
2026
0.03
0.04
- -
- -
- -

Company Description

Company Profile APIChatGPT
CEO
Zhou Rong Liao
Full Time Employees
5,270
Sector
Process industries
Industry
Chemicals: specialty
Address
61 West Section of Gangyuan Road Yibin SI China 644000
IPO Date
Apr 13, 2010
Website
ybty.com
Similar Companies
Petkim Petrokimya Holding Anonim Sirketi (BIST:PETKM)
Albemarle Corporation (NYSE:ALB)
Linde plc (NASDAQ:LIN)
Gubre Fabrikalari T.A.S. (BIST:GUBRF)
IOL Chemicals & Pharmaceuticals Ltd. (NSE:IOLCP)
Dow Inc. (NYSE:DOW)
Business
Yibin Tianyuan Group Co., Ltd. (002386.SZ) operates as a diversified conglomerate primarily engaged in the production and sale of pharmaceuticals, fuses, and copper-based products in China. The company manufactures and distributes a range of core products and services, including fuse products such as low-voltage fuses, high-voltage fuses, and photovoltaic fuses under the Tianyuan brand; pharmaceutical preparations encompassing tablets, capsules, granules, and raw materials like anti-cold medicines and gastrointestinal drugs; and copper processing items such as copper foil, copper strips, and copper wires for applications in electronics and power sectors. It also provides related services in research and development, quality control, and customized manufacturing solutions for industrial clients. Headquartered in Yibin, Sichuan Province, China, the company was founded in 1999 and maintains operations primarily within the domestic Chinese market, with production facilities concentrated in the southwestern region. Yibin Tianyuan Group serves key customer segments including pharmaceutical distributors, electrical equipment manufacturers, renewable energy firms, and electronics producers, operating across the healthcare, electrical components, and new energy materials industries. In recent developments, the company expanded its fuse production capacity through strategic investments in 2024, enhancing output for high-demand photovoltaic and automotive applications amid China's push for renewable energy infrastructure. It formed partnerships with major solar panel producers to supply specialized fuses, bolstering its position in the new energy sector. Additionally, Yibin Tianyuan Group launched new pharmaceutical formulations targeting respiratory and digestive health in late 2024, alongside facility upgrades to meet stringent regulatory standards.